Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. An immunocytochemical study.

Lemere CA, Munger JS, Shi GP, Natkin L, Haass C, Chapman HA, Selkoe DJ.

Am J Pathol. 1995 Apr;146(4):848-60.

2.

Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.

Kung MP, Hou C, Zhuang ZP, Skovronsky D, Kung HF.

Brain Res. 2004 Oct 29;1025(1-2):98-105. Erratum in: Brain Res. 2005 Jan 21;1031(2):302.

PMID:
15464749
4.

Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain.

Taguchi J, Fujii A, Fujino Y, Tsujioka Y, Takahashi M, Tsuboi Y, Wada I, Yamada T.

Acta Neuropathol. 2000 Aug;100(2):153-60.

PMID:
10963362
5.

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Fukumoto H, Cheung BS, Hyman BT, Irizarry MC.

Arch Neurol. 2002 Sep;59(9):1381-9.

PMID:
12223024
6.

Serum IgG brain reactive antibodies in Alzheimer disease and Down syndrome.

Kumar M, Cohen D, Eisdorfer C.

Alzheimer Dis Assoc Disord. 1988;2(1):50-5.

PMID:
2974704
7.

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.

Masliah E, Iwai A, Mallory M, Uéda K, Saitoh T.

Am J Pathol. 1996 Jan;148(1):201-10.

8.

Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease.

Zhou W, Scott SA, Shelton SB, Crutcher KA.

Neuroscience. 2006 Dec;143(3):689-701.

PMID:
16997486
9.
10.

Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system.

Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT.

J Neuropathol Exp Neurol. 1996 Aug;55(8):889-95.

12.

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, Takeuchi M, Makita Z.

Brain Res. 2001 Jan 12;888(2):256-262.

PMID:
11150482
13.

Lack of specific association of presenilin 1 (PS-1) protein with plaques and tangles in Alzheimer's disease.

Xia MQ, Berezovska O, Kim TW, Xia WM, Liao A, Tanzi RE, Selkoe D, Hyman BT.

J Neurol Sci. 1998 Jun 11;158(1):15-23.

PMID:
9667772
14.

Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury.

Calingasan NY, Erdely HA, Altar CA.

Neurobiol Aging. 2002 Jan-Feb;23(1):31-9.

PMID:
11755016
15.
16.

Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.

Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA.

Neurobiol Aging. 2004 Nov-Dec;25(10):1263-72.

PMID:
15465622
17.

Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons.

Wen GY, Wisniewski HM, Blondal H, Benedikz E, Frey H, Pirttila T, Rudelli R, Kim KS.

Acta Neuropathol. 1994;88(3):201-6.

PMID:
7810290
18.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
19.

Apolipoprotein D in the aging brain and in Alzheimer's dementia.

Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG.

Neurol Res. 2000 Jun;22(4):330-6.

PMID:
10874678
20.

Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.

Stockley JH, Ravid R, O'Neill C.

FEBS Lett. 2006 Dec 11;580(28-29):6550-60.

Items per page

Supplemental Content

Support Center